Literature DB >> 22105768

Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.

Guo-Lian Zhu1, Zhe Sun, Zhen-Ning Wang, Ying-Ying Xu, Bao-Jun Huang, Yan Xu, Zhi Zhu, Hui-Mian Xu.   

Abstract

BACKGROUND: Effectiveness of splenectomy for advanced gastric cancers occupying the upper and/or the middle third of the stomach is still in debate. The aim of the present study is to elucidate the impact of splenectomy on patient survival by investigating the pathological characteristics and prognostic significance of splenic hilar lymph node metastasis.
METHODS: Clinicopathologic and prognostic data of 265 patients with gastric cancer in the upper and/or the middle third of the stomach who underwent the operation of en bloc resection of primary cancer and D2/D3 lymphadenectomy combined with splenectomy were retrospectively reviewed.
RESULTS: Multivariate analysis revealed pT category, pN category, and distant lymph node metastasis independently correlated with the presence of splenic hilar lymph node metastasis. Prognoses of patients with positive splenic hilar lymph nodes were significantly poorer than that of patients with negative splenic hilar lymph nodes for the entire study population and for those who underwent R0 resection, but not for those who underwent R1-2 resection. There was no significant difference in survival between patients who underwent R0 resection with positive splenic hilar lymph nodes and those who underwent R1-2 resection. Splenic hilar lymph node metastasis was one of independent indicators predicting worse prognosis and the presence of distant metastasis after surgery. Subset analysis according to the TNM stage revealed there were significant differences in survival between patients with and without splenic hilar lymph node metastasis.
CONCLUSIONS: Splenic hilar lymph node metastasis should be considered as one of incurable factors. Consequently, the efficiency of splenectomy aiming at prolonging survival for patients with high risk of splenic hilar lymph nodes metastasis should be questioned, although resection of invasive organs form gastric cancers has been recommended if R0 surgery could be achieved.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22105768     DOI: 10.1002/jso.22149

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  20 in total

1.  Splenic hilar dissection in the treatment of proximal advanced gastric cancer: what is an adequate strategy?

Authors:  Takahiro Kinoshita
Journal:  Transl Gastroenterol Hepatol       Date:  2016-09-21

2.  The effects of laparoscopic spleen-preserving splenic hilar lymphadenectomy on the surgical outcome of proximal gastric cancer: a propensity score-matched, case-control study.

Authors:  Chang-Ming Huang; Tan Chen; Jian-Xian Lin; Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu
Journal:  Surg Endosc       Date:  2016-07-22       Impact factor: 4.584

Review 3.  Strategies of laparoscopic spleen-preserving splenic hilar lymph node dissection for advanced proximal gastric cancer.

Authors:  Qi-Yue Chen; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Zhi-Liang Hong
Journal:  World J Gastrointest Surg       Date:  2016-06-27

4.  Outcomes of laparoscopic versus open total gastrectomy with D2 lymphadenectomy for gastric cancer: a systematic review and meta-analysis.

Authors:  Yongpu Yang; Yuyan Chen; Yilin Hu; Ying Feng; Qinsheng Mao; Wanjiang Xue
Journal:  Eur J Med Res       Date:  2022-07-18       Impact factor: 4.981

5.  The Role of No. 10 Lymphadenectomy for Advanced Proximal Gastric Cancer Patients Without Metastasis to No. 4sa and No. 4sb Lymph Nodes.

Authors:  Shibo Bian; Hongqing Xi; Xiaosong Wu; Jianxin Cui; Liangang Ma; Rong Chen; Bo Wei; Lin Chen
Journal:  J Gastrointest Surg       Date:  2016-03-03       Impact factor: 3.452

6.  Clinical Significance of Splenic Hilar Dissection with Splenectomy in Advanced Proximal Gastric Cancer: An Analysis at a Single Institution in Japan.

Authors:  Masahiro Watanabe; Takahiro Kinoshita; Naoki Enomoto; Hidehito Shibasaki; Toshirou Nishida
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

7.  Risk factors associated with splenic hilar lymph node metastasis in patients with advanced gastric cancer in northwest China.

Authors:  Zhenqiang Sun; Qisan Wang; Xianbo Yu; Chunlin Ou; Lizhong Yao; Kun Liu; Lin Liu; Lei Ge; Fa Fang; Zeliang Zhao; Haijiang Wang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

8.  Survival benefit and safety of no. 10 lymphadenectomy for gastric cancer patients with total gastrectomy.

Authors:  Kun Yang; Wei-Han Zhang; Xin-Zu Chen; Xiao-Long Chen; Bo Zhang; Zhi-Xin Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

9.  Current status of lymph node dissection in gastric cancer.

Authors:  Bin Ke; Han Liang
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

10.  Metastasis, risk factors and prognostic significance of splenic hilar lymph nodes in gastric adenocarcinoma.

Authors:  Xiao-Long Chen; Kun Yang; Wei-Han Zhang; Xin-Zu Chen; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.